Kimberly Miller, PharmD, completed residencies in pharmacy practice at the University of Maryland Medical Center in Baltimore, and infectious diseases pharmacotherapy at Temple University Hospital in Philadelphia. Her research at Temple focused on the characteristics and cultures of patients with formerly-named healthcare associated pneumonia. After residency, she held several faculty positions. As clinical assistant professor at Temple University School of Pharmacy, she taught medical microbiology and pharmacotherapy, and ran an HIV pharmacotherapy and HIV/hepatitis C co-infection clinic where she precepted pharmacy students. Additionally, she taught anti-infective pharmacotherapy as an adjunct professor at Drexel and Philadelphia universities in their physician assistant programs. As an assistant professor at Wilkes University Nesbitt School of Pharmacy, Dr. Miller taught medical microbiology and ambulatory care practice. Dr. Miller’s professional experience also includes clinical hospital pharmacy, the pharmaceutical industry and ambulatory care.
Dr. Miller’s research interests include antimicrobial resistance, population health and medical education.
- “Treatment Considerations for Unique Patient Populations for Patients with HCV Genotype 1 Infection.” Toussaint-Miller KA and Andres J. Ann Pharmacother 2015;Sep;29(9):1015-30.
- “Beta-lactam/beta-lactamase inhibitors: From then to now.” Toussaint KA, Gallagher JC. Ann Pharmacother 2015;49(1):86-98.
Temple University School of Pharmacy (2010)